|
DMAE
DMAE alleviates the behavioral problems and hyperactivity
associated with Attention Deficit Disorder (ADD) [DMAE increases Attention Span,
decreases Aggression, improves Learning ability and sometimes increases
Intelligence in 70% of ADD patients].
DMAE increases Attention Span [after 6 weeks of DMAE supplementation students
were able to concentrate at lectures better].
DMAE inhibits and reverses the Cross-Linking of proteins.
DMAE extends the lifespan of mice by 27-49%.
to
order
DMAE facilitates the removal of Lipofuscin from Neurons.
DMAE decreases the incidence and severity of Hangovers. [after 6 weeks of DMAE use subjects reported
freedom from the depression or headaches associated with hangovers].
Most people who use DMAE supplements report that after 3-4 weeks of DMAE use,
they notice a continual mild stimulation without side effects.
DMAE increases Alertness.
DMAE alleviates Anxiety [subjects administered 1,200 mg of DMAE per day for 5
days exhibited better control of anxious reactivity].
DMAE increases Assertiveness [after 6 weeks of DMAE supplementation subjects
reported having a more outspoken personality].
DMAE reduces Apathy and increases Motivation in persons with
Depression.
DMAE improves the Interhemispheric Flow of Information across the Corpus Callosum of
the Brain (thereby improving Creativity and Verbal Fluency).
DMAE improves the behavior and mental function of children with
Down’s Syndrome.
DMAE exerts favorable effects on those chronic Dyskinesias (including Tardive
Dyskinesia) that occur as a result of long periods of use of Major
Tranquilizers.
DMAE increases Intelligence (especially in children).
DMAE improves Learning and Memory.
DMAE decreases the accumulation of the age pigment Lipofuscin within the Brain.
DMAE elevates Mood [after 6 weeks of DMAE, subjects reported
more affable moods].
DMAE reduces the amount of Sleep required by about 1 hour per night [this effect
noted after 6 weeks of DMAE use].
DMAE causes Dreams to become more vivid.
DMAE users experience a sounder Sleep [after 6 weeks subjects reported waking
earlier and having a clearer mind upon waking].
DMAE increases daytime motivation and energy in persons with
Insomnia.
DMAE increases willpower [after 6 weeks of DMAE use, subjects who previously
were unable to stop smoking reported success].
DMAE removes Lipofuscin (age spots) from the skin.
DMAE increases Acetylcholine levels within the Brain:
DMAE increases the content of Ribonucleic Acid (RNA) in the Brain [research -
rats].
DMAE increases the concentration of Choline in the bloodstream because it
enhances the rate at which free Choline enters the blood from other tissues:
DMAE increases the levels of Choline in the brain due to DMAE’s superior
ability to cross the Blood-Brain Barrier.
References
· Pfeiffer, C., et al. Stimulant effect of 2-Dimethyl-l-aminoethanol (DMAE):
Possible precursor of brain acetylcholine. Science. 126:610-611, 1957.
· Caille, E. J. Study concerning the bisorcate demanol effects upon quantified
EEG, cortical vigilance and mood. Comparative double-blind, cross-over balanced
design versus pirisudanol. Psychol. Med. 18:2069-2086, 1986.
· Pieralisi, G., et al. Effects of a standardized ginseng extract combined with
dimethylaminoethanol bitartrate (DMAE), vitamins, minerals and trace elements on
physical performance during exercise. Clin Ther. 13(3):373-382, 1991.
· Coleman, N., et al. DMAE in the treatment of hyperactive children.
Psychosomatics. 17:68-72, 1976.
· Knoble, M. 2-Dimethylaminoethanol (DMAE) in behavior problems of children.
Science Medicine (Buenos Aries). 119:939-944, 1961.
· Lewis, J. A., et al. DMAE and methylpheni date in minimal brain dysfunction.
Clin Pharmacol Ther. 17:534-540, 1975.
· Oettinger, L. The use of DMAE in the treatment of disorders of behavior in
children. Journal of Pediatrics. 53:671-675, 1958.
· Murphree, H. B., et al. The stimulant effect of 2-diethylaminoethanol (DMAE)
in human volunteer subjects. Clinical Pharmacology and Therapeutics. 1:303-310,
1960.
· Ceder, G., et al. Effects of 2-Dimethylaminoethanol (DMAE) on the metabolism
of choline in plasma. Journal of Neurochemistry. 30:1293-1296, 1978.
· Zs-Nagy, I., et al. On the role of cross-linking of cellular proteins in
aging. Mech Aging Dev. 14:245-251, 1980.
· Sergio, W. Use of DMAE (2-dimethylaminoethanol) in the induction of lucid
dreams. Medical Hypotheses. 26:255-257, 1988.
· Hochschild, R. Effect of dimethylaminoethyl (DMAE) p chlorophenoxyacetate on
the life span of male swiss webster albino mice. Exp Geront. 6:133, 1971.
· Pfeiffer, C. C. Parasympathetic neurohumors. Possible precursors and effect
on behavior. International Review of Neurobiology. 1959:195-244.
· Rosenberg, G. S., et al. The use of cholinergic precursors in
neuropsychiatric diseases. American Journal of Clinical Nutrition. 36:709-720,
1982.
· Lambert, P. A., et al. Dimethylaminoethanol (DMAE) in the treatment of late
dyskinesia induced by neuroleptic drugs. Ann Med Psychol. 136:625-629, 1978.
· Stafford, J. R., et al. Deanol acetamidobenzoate (DMAE) in tardive
dyskinesia. Diseases of the Nervous System. 38:3-6, 1977.
|